Prescription-strength ibuprofen linked to heart failure

New research shows that prescription-strength ibuprofen, naproxen and other pain relievers could contribute to a higher risk for heart failure for some individuals, according to CBS News.

The medication could raise a person’s risk of heart failure by almost 20 percent, according to a study led by Andrea Arfe, PhD, a student at the university of Milano-Bicocca in Italy. The study, which analyzed medical records for nearly 10 million patients, was published Sept. 28 in The BMJ.

Pain-killers, when prescribed at a high dose, can also increase a person’s risk of hospitalization for heart failure. Drugs like diclofenac, etoricoxib and indomethacin are some that can put a person at higher risk.

To read more about the study and the connection between painkillers and heart failure, follow the link below. 

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup